Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk

(2013) Haseeb Jafri et al.   ANNALS OF INTERNAL MEDICINE

Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada

(2011) Manoela F.B. Braga et al.   CANADIAN JOURNAL OF CARDIOLOGY

Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada

(2011) Anselm K Gitt et al.   European Journal of Preventive Cardiology

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis

(2009) Heinz Drexel et al.   ATHEROSCLEROSIS

Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines

(2009) Pierluigi Tricoci   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

(2009) Jennifer G. Robinson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

(2008)   LANCET